Login to Your Account

La Jolla gifted early stocking stuffer with FDA shock drug approval

By Michael Fitzhugh
Staff Writer

Friday, December 22, 2017

Two months ahead of its PDUFA date, La Jolla Pharmaceutical Co. has won FDA approval for a new vasopressor capable of increasing blood pressure in adults with septic or other distributive shock.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription